MedTech Industry Leader Jeffrey Goble Appointed to ThermoFab’s Advisory Board
ThermoFab announced today the appointment of Mr. Jeffrey Goble to its Board of Advisors, effective immediately. “We are delighted to welcome Jeff to the Advisory Board,” said Adam Cook, Non-Executive Chairman and Chief Investment Officer of Culper Capital Partners. “Jeff brings an exceptional track record of building and scaling global MedTech manufacturing platforms. His industry knowledge, visionary leadership, and impressive history of founding and growing successful companies in the medical device space make him a tremendous asset to ThermoFab’s continued growth. Our CEO Mark Rauenzahn, Board Member Declan Smyth (Med Device Executive) and Board Member Dean Schauer (CEO & President Confluent Medical Technologies), all are leaders with deep roots in the medical device space. I’m personally excited to see this team drive the next phase of our journey.”
Mr. Goble is a founder and current President & CEO of Arterex, a diversified global contract development and manufacturing organization serving leading MedTech OEMs and innovators. With 13 facilities across five countries and four continents, Arterex is a major player in the medical technology manufacturing space. Prior to Arterex, Mr. Goble was a founder and served as President & CEO of Providien, LLC, a diversified manufacturer of medical devices and outsourced manufacturing services for the life sciences industry, which was acquired by Carlisle Companies in 2019. He also held executive leadership positions at Medegen, Inc., where he led the company through a successful acquisition to CareFusion in 2010.
“I’m honored to join ThermoFab’s Advisory Board,” said Mr. Goble. “ThermoFab is well positioned for continued growth. I’m excited to contribute to the next phase of ThermoFab’s future alongside Adam, Declan, and the rest of the leadership team.”
